Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Publish date: September 9, 2024 Background Agent Orange (AO) exposure may be linked to development of myeloid malignancies, including myelodysplastic syndrome (MDS). This is not yet definitive, though, and, unlike several other malignancies, MDS is not yet a service-connected diagnosis for AO. Although recent studies have not revealed AO associated specific mutations in MDS, other clinical and pathological potential differences have not been well described.
Research ArticleClinical Studies CHAIM DOMB, TIMOTHY D. SMILE, CHANDANA REDDY, NEIL M. WOODY, SHAUNA R. CAMPBELL, JOYCELIN F. CANAVAN, NIKHIL P. JOSHI, JOHN F GRESKOVICH, DEBORAH J. CHUTE, BRIAN B. BURKEY, LAMIE A. KU, ERIC LAMARRE, ROBERT R. LORENZ, BRANDON PRENDES, JOSEPH SCHARPF, LARISA SCHWARTZMAN, JESSICA L. GEIGER, SHLOMO A. KOYFMAN and CHRISTOPHER W.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
